Q8BH02
Gene name |
Tor4a |
Protein name |
Torsin-4A |
Names |
Torsin family 4 member A |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:227612 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q8BH02
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q8BH02-F1 | Predicted | AlphaFoldDB |
36 variants for Q8BH02
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs229594262 | 42 | P>S | No | EVA | |
| rs3411698940 | 44 | T>I | No | EVA | |
| rs3388527084 | 48 | S>Y | No | EVA | |
| rs3388535497 | 64 | A>V | No | EVA | |
| rs3388530132 | 78 | T>I | No | EVA | |
| rs3388532595 | 81 | T>I | No | EVA | |
| rs3388536308 | 104 | C>S | No | EVA | |
| rs3388535509 | 107 | R>C | No | EVA | |
| rs3388533026 | 116 | R>C | No | EVA | |
| rs28257729 | 120 | L>F | No | EVA | |
| rs3388531420 | 133 | I>T | No | EVA | |
| rs3388531838 | 134 | E>K | No | EVA | |
| rs3388527143 | 157 | F>L | No | EVA | |
| rs3388527086 | 174 | L>M | No | EVA | |
| rs3388531869 | 174 | L>P | No | EVA | |
| rs3388535550 | 179 | H>Y | No | EVA | |
| rs3388527116 | 196 | S>C | No | EVA | |
| rs240996919 | 208 | A>S | No | EVA | |
| rs3388529499 | 222 | R>* | No | EVA | |
| rs3388528128 | 228 | P>T | No | EVA | |
| rs242820611 | 230 | P>L | No | EVA | |
| rs3388534887 | 265 | L>V | No | EVA | |
| rs3388533979 | 285 | H>D | No | EVA | |
| rs3388531814 | 286 | F>L | No | EVA | |
| rs3388534308 | 292 | V>E | No | EVA | |
| rs3388531793 | 298 | G>D | No | EVA | |
| rs3388528215 | 302 | I>V | No | EVA | |
| rs3388532634 | 308 | Q>H | No | EVA | |
| rs3388531440 | 309 | N>I | No | EVA | |
| rs28257735 | 332 | Q>E | No | EVA | |
| rs3388532637 | 332 | Q>H | No | EVA | |
| rs3388533932 | 350 | H>Q | No | EVA | |
| rs3388531832 | 362 | K>R | No | EVA | |
| rs3388532989 | 376 | E>K | No | EVA | |
| rs3388531389 | 378 | F>L | No | EVA | |
| rs28257737 | 425 | G>E | No | EVA |
No associated diseases with Q8BH02
1 regional properties for Q8BH02
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | AAA+ ATPase domain | 181 - 317 | IPR003593 |
3 GO annotations of cellular component
| Name | Definition |
|---|---|
| endoplasmic reticulum lumen | The volume enclosed by the membranes of the endoplasmic reticulum. |
| integral component of membrane | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| nuclear envelope | The double lipid bilayer enclosing the nucleus and separating its contents from the rest of the cytoplasm; includes the intermembrane space, a gap of width 20-40 nm (also called the perinuclear space). |
2 GO annotations of molecular function
| Name | Definition |
|---|---|
| ATP binding | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
| ATP hydrolysis activity | Catalysis of the reaction: ATP + H2O = ADP + H+ phosphate. ATP hydrolysis is used in some reactions as an energy source, for example to catalyze a reaction or drive transport against a concentration gradient. |
No GO annotations of biological process
| Name | Definition |
|---|---|
| No GO annotations for biological process |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MDRSHPSLEP | QAKGPCVIAP | VRAVLRLRRR | VCVLRKRRLL | QPGTEPDSGT | GTLGPTGSLG |
| 70 | 80 | 90 | 100 | 110 | 120 |
| TLRADLDQPK | FFTFDSLTEL | TSRTPRKRRR | RSRVVLYPET | SRKCRPRTER | QSRAQRCLLL |
| 130 | 140 | 150 | 160 | 170 | 180 |
| LVAIVGFQVL | NAIENLDDNA | QRYDLDGLEK | ALQRSVFGQP | AAVGRIMALL | RDYLATHVHS |
| 190 | 200 | 210 | 220 | 230 | 240 |
| HPLLLALHGP | SGVGKSHVGR | LLARHFRAVL | EDGALVLQYH | ARYHCPEPRP | VQDCRKELAQ |
| 250 | 260 | 270 | 280 | 290 | 300 |
| RVADVVAQAE | AEEKTPLLVL | DEAELLPPAL | LDELHDLLQP | QRSHHFHNAI | YVLLSGAGGI |
| 310 | 320 | 330 | 340 | 350 | 360 |
| EITHFVLQNA | SRMLPPLRHS | AGSTQTEESP | AQELLTSLRE | LLAREHPLWH | TAAIVPFLLL |
| 370 | 380 | 390 | 400 | 410 | 420 |
| DKPDVVNCFR | EEMAGEGFFP | EQALAEHLAE | QLSYYHVAGH | EFAITGCKQV | VAKVNLLQHK |
| PAHAGH |